CVS Health Corporation$100.05MDLZ · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $38.54B | $36.44B | $36.02B | $31.50B | $28.72B | $26.58B | $25.87B | $25.94B |
| Cost of Revenue | $27.60B | $22.18B | $22.25B | $20.18B | $17.47B | $16.14B | $15.53B | $15.59B |
| Gross Profit | $10.94B | $14.26B | $13.76B | $11.31B | $11.25B | $10.45B | $10.34B | $10.35B |
| Research & Development | $400.00M | $400.00M | $380.00M | $346.00M | $347.00M | $332.00M | $351.00M | $362.00M |
| Selling, General & Administrative | $7.17B | $7.44B | $8.00B | $7.38B | $6.26B | $6.10B | $6.14B | $6.47B |
| Operating Income | $3.55B | $6.34B | $5.50B | $3.53B | $4.65B | $3.85B | $3.84B | $3.31B |
| Interest Expense | $599.00M | $508.00M | $550.00M | $428.00M | $365.00M | $423.00M | $484.00M | $462.00M |
| Other Income / (Expense) | -$282.00M | -$180.00M | -$310.00M | -$423.00M | -$447.00M | -$608.00M | -$456.00M | -$520.00M |
| Income Before Taxes | $3.01B | $6.26B | $5.88B | $3.23B | $4.37B | $3.38B | $3.45B | $2.84B |
| Provision for Income Taxes | $782.00M | $1.47B | $1.54B | $865.00M | $1.19B | $1.22B | $2.00M | $773.00M |
| Net Income | $2.45B | $4.61B | $4.96B | $2.72B | $4.30B | $3.56B | $3.93B | $3.32B |
| Basic EPS | $1.89 | $3.44 | $3.64 | $1.97 | $3.06 | $2.48 | $2.72 | $2.25 |
| Diluted EPS | $1.89 | $3.42 | $3.62 | $1.96 | $3.04 | $2.47 | $2.69 | $2.23 |
| Basic Shares Outstanding | 1.29B | 1.34B | 1.36B | 1.38B | 1.40B | 1.43B | 1.45B | 1.47B |
| Diluted Shares Outstanding | 1.30B | 1.35B | 1.37B | 1.39B | 1.41B | 1.44B | 1.46B | 1.49B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $3.05 | $3.00 | $3.10 | 8 | ↑2 ↓3 |
| Dec 2027 | $3.38 | $3.32 | $3.41 | 8 | ↑0 ↓3 |
| Dec 2028 | $3.74 | $3.66 | $3.90 | 3 | ↑0 ↓0 |
| Dec 2029 | $4.11 | $3.94 | $4.29 | 2 | ↑0 ↓0 |
